Share on facebook
Share on twitter
Share on linkedin
Share on telegram
Share on whatsapp

Modified spike protein RNA injection-induced Amyloidosis?

Share on facebook
Share on twitter
Share on telegram
Share on email
Share on print

Say that five times fast.

By Jessica Rose

Well that title is a handful, isn’t it.

I just want to first say how odd it is that General Practitioners all over the world haven’t been singing AMYLOIDOSIS at the tops of their lungs for months. This, to me, is such a perfect fit.1 Walter Chestnut wrote this up as well. Many times. I applaud you for seeing what I did not.

What is amyloidosis? Amyloidosis comprises diseases that result from protein aggregation of fibrous proteins called amyloids. These amyloids can be formed as the by-product of inflammatory responses and infection in the human body and can also be iatrogenic.

I think humans really need to stop. Like, really STOP. With all the bullshit criminal behaviour. Against nature. Against each other. Against science. Protein mis-folding is very serious. No cure. I wrote this up. Adverse event reports of Creutzfeldt-Jacob Disease are up to 41.2 As usual, reaching for band-aid solutions instead of root causes and destroying the source of the problem. Man. I digress.

This is a crystal structure that was resolved from work you can read about here. I chose it for no particular reason – to illustrate the beta-sheet alignment that gives the fibrils their visual appearance that you can observe using cryo-transmission electron microscopy.

A paper was published on May 17, 2022 entitled: “Amyloidogenesis of SARS-CoV-2 Spike Protein” and it nails this down in my opinion. They propose that the protease neutrophil elastase (NE) which is overexpressed at sites of inflammation, cut the spike protein into amyloidogenic bits. This means that those amyloidogenic bits produce amyloid deposits. Those amyloid deposits look like this (right) using negative stain transmission electron microscopy (TEM):
J. Am. Chem. Soc. 2022, XXXX, XXX, XXX-XXX

Richard Hirschman found fibrous clots in some of the bodies he had embalmed. He’s an embalmer, don’t worry. He referred to these structures as “white stringy fibrous tissue”.

These amyloid deposits don’t get broken down and disrupt the normal functioning of cells and tissues affected, and unfortunately, can affect pretty much all tissues. This, in my opinion, is the reason for the carditis’s we are seeing. Amyloid deposits in the myocardium, pericardium and endocardium. Amyloid cardiomyopathy.

Make no mistake: these shots are massively dangerous. You truly take an enormous risk by getting injected with this modified spike protein, in my opinion. It absolutely has associations with prion-like illnesses with demonstrable amyloidygenic properties.

I leave my readers to decide for themselves what they think is going on here, but I strongly believe that these modified spike proteins were made to be destructive. It cannot be that intelligent experimentalists did not know the potential dangers associated with what they created. The modifications are too precise and targetted. These prion-like proteins work entirely against an optimally-functioning human physiological being, and they could be the link between all adverse events and disease symptoms we are seeing in adverse event data and clinically: neurological, (CJD), immunological, cardiovascular, hepatological, etc…

One thing that does bother me is that people are playing with amyloid fibrils and applying it to tech. The authors listed in reference 1 (some of the players) are funded by the Wellcome Trust.

The amyloid fibril has been increasingly examined for its potential role in forming nanotubular scaffolding for bionanotechnology. [1]

Risk factors for amyloidosis include age (60+), gender (male), race (African descent), genetic predisposition and chronic infectious or inflammatory diseases.3

I don’t think there’s any doubt that these modified spike proteins are amyloidygenic, thus being one of the big reasons for the atypical numbers and diversity of adverse event reports in VAERS, the Yellowcard and the EUDRA systems. (I still think the lipid nanoparticles are bad news, as well.)

I leave you with some Amyloidosis adverse event data from VAERS. I included diagnostic markers like “D-dimer” and “Transthyretin” as well.

It’s never Lupus.1

Rambaran RN, Serpell LC. Amyloid fibrils: abnormal protein assembly. Prion. 2008;2(3):112-117. doi:10.4161/pri.2.3.7488.2

There are typically 350 cases per year in the U.S. so if we consider the upder-reporting factor of only 9, we have exceeded our background for the year.3

Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x

Get in Touch!

Purpose of your Contact
Where can i reach you?
What would you like to discuss?

Are you intending to visit the Lorphic marketing agency?